News | September 24, 2013

Varian and Siemens to Showcase Collaborative Offerings at 2013 ASTRO

September 24, 2013 — Varian Medical Systems and Siemens Healthcare showcased a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO).
 
Connecting Varian's ARIA Software to Siemens Linear Accelerators
As part of their EnVision Better Cancer Care global strategic partnership, the two companies showcased Varian Exchange, a new interface for connecting Varian's Aria oncology information system with Siemens' Artiste medical linear accelerators. (Note: pending FDA clearance and not commercially available in the United States due to regulatory reasons, future availability cannot be guaranteed.)
 
Earlier this year, Varian and Siemens announced an interface that connected Aria with Siemens' Oncor and Primus accelerators. "That first phase of interface development enabled us to connect Aria with about 80 percent of Siemens treatment machines," said Karla Donohoe, vice president of strategic planning for Varian's oncology systems business. "With this new interface, we will have connectivity available for a full range of Siemens treatment machines, allowing us to offer a seamless solution for using them with Aria to deliver quality cancer care."
 
Varian Brachytherapy Powered by Siemens Sliding Gantry Imaging
Varian and Siemens will also showcase the pairing of a Siemens Somatom CT Sliding Gantry scanner with Varian brachytherapy technology to enable 3-D image-guided high-dose-rate (HDR) brachytherapy procedures within a single treatment room.
 
HDR brachytherapy involves delivering radiotherapy from inside the body by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. Using a robotic afterloader, clinicians place the radioactive source into positions through applicators that have been inserted into the area being treated.
 
"HDR brachytherapy treatments are planned using anatomical images of the targeted area taken after applicators have been put in place," said Tim Clark, marketing manager for Varian brachyTherapy. "The Siemens Sliding Gantry CT is ideal for use right in the brachytherapy treatment room, so the patient doesn't have to be moved to another room for scanning. It has the potential to minimize patient transport and possible applicator motion, which could compromise accuracy. Image quality is much superior to what is possible using conventional X-rays or ultrasound imaging."
 
Respiratory Gating and CT Imaging
Varian and Siemens also showcased the interoperability of a Siemens' CT scanner with Varian's Real-time Position Management (RPM) system. The brand new Biograph mCT Flow PET/CT scanner that Siemens will unveil at ASTRO also works in conjunction with Varian's RPM system.
 
"The RPM system, when used in conjunction with imaging, enables clinicians to understand how a tumor moves during a treatment," says Donohoe. "This makes it possible to compensate for tumor motion while planning and delivering radiotherapy treatments in the lung and other parts of the body that are subject to respiratory motion. By using these technologies together, cancer specialists can design and deliver treatments that minimize exposure of healthy tissues."
 
For more information: www.varian.com
 

Related Content

Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).

Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline). See more figures from this study.

Feature | Radiation Therapy | September 28, 2021
September 28, 2021 — New research from Washington University School of Medicine in St.
The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%

Varian's Ethos artificial intelligence radiotherapy device.

News | Radiation Oncology | September 28, 2021
September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848
GE Healthcare unveiled Revolution Ascend with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to deliver more personalized care to more patients.
News | Computed Tomography (CT) | September 27, 2021
September 27, 2021 — GE Heal
Zebra Medical Vision now offers artificial intelligence (A) medical imaging analytics for its cardiac solution HealthCCSng, which enables the quantification of the coronary artery calcium (CAC) on CT scans as an incidental finding.
News | Artificial Intelligence | September 27, 2021
September 27, 2021 — Zebra Medical Vision, the deep-learning medical imaging analytics company, announces its eighth
Volpara Health, a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market with a strategic relationship with Seattle-based lung AI company RevealDx.

Getty Images

News | Lung Imaging | September 27, 2021
September 27, 2021 — Volpara Health, a global health technology software leader providing an integrated platform for
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me